Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
83 enrolled 21 charts
VITAL
Phase 3 Completed
913 enrolled 16 charts
SAMCO
Phase 2 Completed
132 enrolled
PROTECT
Phase 3 Completed
57 enrolled
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Phase 2 Completed
56 enrolled 14 charts
Resection Observatory
Completed
140 enrolled
ZETA
Completed
120 enrolled
FOLFA
Phase 2 Completed
117 enrolled 12 charts
VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Phase 2 Completed
75 enrolled 15 charts
ELDERLY
Phase 2 Completed
124 enrolled
Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
Phase 2 Completed
19 enrolled 11 charts
AFEMA
Phase 2 Completed
170 enrolled
mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer
Phase 2 Completed
119 enrolled
Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer
Phase 2 Completed
41 enrolled 8 charts
RIA
Phase 2 Completed
180 enrolled 15 charts
Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 2 Completed
22 enrolled 10 charts
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
Phase 2 Completed
64 enrolled 11 charts
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase 2 Completed
49 enrolled 13 charts
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Phase 2 Completed
84 enrolled 13 charts
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 1/2 Completed
58 enrolled 16 charts
X-TRAP
Phase 1/2 Completed
63 enrolled 12 charts
VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Phase 2 Completed
41 enrolled 7 charts
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Phase 3 Completed
781 enrolled 28 charts
MOMENTUM1
Phase 1 Completed
37 enrolled
AMALTHEA
Phase 2 Completed
73 enrolled
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
189 enrolled 15 charts
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Phase 2 Completed
94 enrolled 8 charts
Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Phase 2 Completed
41 enrolled 10 charts
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Phase 2 Completed
62 enrolled 34 charts
VELVET
Phase 2 Completed
49 enrolled
5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
Phase 2 Completed
39 enrolled 13 charts
AFEQT
Phase 3 Completed
175 enrolled 6 charts
AFLAME
Phase 3 Completed
332 enrolled 9 charts
VENICE
Phase 3 Completed
1,224 enrolled 21 charts
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer
Phase 2 Completed
218 enrolled 19 charts
AFFIRM
Phase 2 Completed
268 enrolled 16 charts
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
25 enrolled
Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma
Phase 1 Completed
25 enrolled
QUTIE
Phase 1 Completed
88 enrolled
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Phase 2 Completed
63 enrolled 10 charts
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
Phase 2 Completed
58 enrolled 12 charts
Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies
Phase 1 Completed
48 enrolled
A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies
Phase 1 Completed
20 enrolled
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
Phase 2 Completed
22 enrolled 7 charts
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Phase 1 Completed
61 enrolled
VEGF Trap in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
21 enrolled 22 charts
Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
27 enrolled